Last quarter (Q2 2024), Biomerica's total revenue was $1.57M, an increase of 5.74% from the same quarter last year. In Q2, Biomerica's net income was $-1.51M. See Biomerica’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	May 23	May 22	May 21	May 20	May 19
Total Revenue	$ 5.50M	$ 5.34M	$ 18.87M	$ 7.20M	$ 6.69M	$ 5.20M
Cost of Revenue	$ 5.37M	$ 4.89M	$ 15.89M	$ 6.83M	$ 4.95M	$ 3.91M
Gross Profit	$ 5.78M	$ 446.00K	$ 18.87M	$ 366.29K	$ 1.74M	$ 1.29M
Operating Expense	$ 15.28M	$ 7.67M	$ 7.51M	$ 7.87M	$ 4.48M	$ 3.70M
Operating Income	$ -1.43M	$ -7.22M	$ 11.36M	$ -7.50M	$ -2.74M	$ -2.41M
Net Non Operating Interest Income Expense	-	-	-	$ -367.00	$ -9.00	$ 43.97K
Other Income Expense	$ -92.72K	$ -134.00K	$ -27.00K	$ 66.86K	$ 71.19K	-
Pretax Income	$ -6.00M	$ -7.09M	$ -4.51M	$ -7.43M	$ -2.67M	$ -2.37M
Tax Provision	$ 78.79K	$ 51.00K	$ 24.00K	$ 13.06K	$ 7.39K	$ 24.24K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -6.08M	$ -7.14M	$ -4.53M	$ -7.45M	$ -2.68M	$ -2.39M
Basic EPS	$ -0.38	$ -0.50	$ -0.36	$ -0.54	$ -0.23	$ -0.26
Diluted EPS	$ -0.38	$ -0.50	$ -0.36	$ -0.54	$ -0.23	$ -0.26
Basic Average Shares	$ 61.28M	$ 14.15M	$ 12.67M	$ 11.93M	$ 10.17M	$ 9.21M
Diluted Average Shares	$ 61.28M	$ 14.15M	$ 12.67M	$ 11.93M	$ 10.17M	$ 9.21M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 20.64M	$ 7.67M	$ 7.51M	$ 14.70M	$ 9.43M	$ 7.61M
Net Income From Continuing And Discontinued Operation	$ -6.08M	$ -7.14M	$ -4.53M	$ -7.45M	$ -2.68M	$ -2.39M
Normalized Income	$ 2.21M	$ -707.31K	-	$ -7.50M	$ -2.73M	$ -2.39M
Interest Expense	-	-	-	$ 367.00	$ 9.00	$ 47.00
EBIT	$ -6.00M	$ -7.09M	$ -4.51M	$ -7.43M	$ -2.67M	$ -2.37M
EBITDA	$ -5.65M	$ -6.74M	$ -3.91M	$ -7.06M	$ -2.27M	$ -2.21M

Currency in USD

Biomerica Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing